Rafferty Asset Management, LLC
Position in ALLO — Allogene Therapeutics, Inc.
CIK 1389426
New York, NY
Position in ALLO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$688,924
-$93,733 QoQ
Shares Held
282,346
-23.2% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALLO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rafferty Asset Management, LLC holds $409,131,399 across 136 Biotechnology names. ALLO ranks #115 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
54,572 | $24,368,580 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
29,589 | $22,861,644 | |
| 3 | INSM |
INSMED Inc
|
116,069 | $18,979,602 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
50,553 | $16,726,471 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
|
180,471 | $7,260,348 | |
| 6 | MRNA |
Moderna, Inc.
|
114,194 | $5,801,055 | |
| 7 | INCY |
Incyte Corp
|
60,565 | $5,700,377 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
10,452 | $5,471,308 |
All Filings in ALLO
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $688,924 | 282,346 | Shares | Sole | 2026-05-15 | |
| 2024-12-31 | $782,657 | 367,445 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $887,448 | 316,946 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,362,677 | 584,840 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,428,442 | 990,703 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $735,115 | 229,008 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,866,957 | 904,403 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,396,317 | 884,571 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,344,562 | 677,037 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,758,435 | 756,508 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,966,174 | 459,831 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,529,192 | 221,859 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,173,732 | 567,918 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,407,054 | 295,379 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,373,921 | 131,281 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,606,513 | 99,943 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,056,379 | 86,583 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $858,109 | 33,998 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,310,755 | 61,277 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $978,394 | 22,849 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||